Caglar, CagatayYasar, TekinCeyhan, Dogan2025-05-102025-05-1020121080-768310.1089/jop.2011.01612-s2.0-84859402698https://doi.org/10.1089/jop.2011.0161https://hdl.handle.net/20.500.14720/1171Caglar, Cagatay/0000-0003-4391-2571Purpose: The aim of this article is to create awareness among medical colleagues regarding the severe ophthalmic side effects associated with topiramate use. Methods: A case of severe acute bilateral angle closure glaucoma with visual blurring after oral topiramate therapy. Results: This case was successfully managed by discontinuing topiramate and by starting anti-glaucoma medication. Intraocular pressure, acute transient myopia, and anterior chamber depth were normalized. Conclusions: It is important for clinicians to recognize these conditions and educate patients about these serious adverse effects when prescribing topiramate.eninfo:eu-repo/semantics/closedAccessArticle282Q3Q320520722149720WOS:000302477600018